Written question asked by Catherine West (Labour) on Monday, 17 May 2021, in the House of Commons. It was due for an answer on Wednesday, 19 May 2021. It was answered by Jo Churchill (Conservative) on Friday, 21 May 2021 on behalf of the Department of Health and Social Care.
Epilepsy: Cannabis
- Question
-
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 26 March 2021 to Question 134037, what steps his Department has taken to ensure the continued supply of Bedrocan oils for the treatment of severe epilepsy in advance of the end of the existing agreement on 1 July 2021.
- Answer
-
The Dutch Government has agreed to a further six months extension, to allow continued access to Bedrocan oils - a form of unlicensed cannabis-based product for medicinal use - produced in the Netherlands until 1 January 2022.
We will continue to work closely with the Dutch Government to secure a permanent solution.
Secondary information
- Type
- Written question
- Reference
- 2388
- Session
- 2021-22
- Related items
- Subjects
- Cannabis Epilepsy Medical treatments
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-05-21 16:09:04 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/2388
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/2388
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/2388